Welcome to the e-CCO Library!

P555: Ustekinumab tissue and serum levels in patients with Crohn’s disease are closely correlated though not consistently associated with objective response after induction.
Year: 2022
Source: ECCO'22
Authors: Proietti, E.(1,2);Bayoumy, A.(1);Pauwels, R.(1);van der Woude, J.(1);Doukas, M.(3);Oudijk, L.(3);Peppelenbosch, M.(1);Grohmann, U.(2);Crombag, R.(4);de Vries, A.(1);Fuhler, G.(1);
Created: Friday, 11 February 2022, 3:56 PM
P556 Long-term probability of retreatment with anti-TNF therapy after discontinuation based on mucosal healing in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A.M. Luque Carmona, J.M. García Ortíz, A. Nuñez Ortiz, M.D. De la Cruz Ramírez, J.M. Herrera Justiniano, E. Leo Carnerero

Created: Thursday, 30 January 2020, 10:12 AM
P556: Cyclosporine in acute severe steroid-refractory ulcerative colitis: Short-and long-term outcomes
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Hammami*, B. Hasnaoui, S. Hachicha, M. Ksiaa, H. Jaziri, N. Elleuch, A. Brahem, S. Ajmi, A. Ben Slama, A. Jmaa

Created: Thursday, 21 February 2019, 9:14 AM
P556: Female Crohn's disease patients and ulcerative colitis patients on biologic therapy are most disabled
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Spizzo P.

Created: Wednesday, 20 February 2019, 10:36 AM
P556: Safety and efficacy of ustekinumab in the treatment of Crohn's Disease: A systematic review and meta-analysis
Year: 2021
Source: ECCO'21 Virtual
Authors: KhorshidFASGE, M.(1);Cordie, A.(2);Abd-Elsalam, S.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P556: Surgery in high-risk paediatric Crohn's Disease treated with up-front anti-TNF agents and long-standing biologic therapy
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Musto, F.(1)*;Distante, M.(2);Dei Rossi, E.(2);Calicchia, A.(3);Veraldi, S.(4);Mondi', F.(2);Tarani, F.(2);D'Arcangelo, G.(2);Aloi, M.(2);
Created: Friday, 14 July 2023, 11:05 AM
P556: The effect of multiple doses of upadacitinib 45 mg on the pharmacokinetics of cytochrome P450 substrates in healthy adult subjects
Year: 2022
Source: ECCO'22
Authors: Ibrahim, M.(1);Pangan, A.(2);Feng, T.(3);Mohamed, M.E.(1);
Created: Friday, 11 February 2022, 3:56 PM
P556: The prevalence of metabolic bone disease in patients with IBD- preliminary results from POLIBD study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Sztembis1, D. Piątek2, S. Jarmakiewicz3, P. R. Kiela4, R. Filip*5,6

Created: Friday, 22 February 2019, 9:41 AM
P557 Increased risk of anastomotic leak in Crohn’s disease patients unable to complete preoperative mechanical bowel preparation
Year: 2020
Source:

ECCO'20 Vienna

Authors:

I. Iesalnieks1, F. Marek2, Z. Kala2, L. Kunovsky3

Created: Thursday, 30 January 2020, 10:12 AM
P557: Analysis of colectomy rates and advanced therapy prescribing for ulcerative colitis in Lothian; Scotland an updated population based cohort study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Jenkinson, P.(1)*;Plevris, N.(2);Gros Alcalde, B.(2);Lyons, M.(2);Derikx, L.(2);Constantine-Cooke, N.(3);Arnott, I.(2);Jones, G.(2);Lees, C.(2);
Created: Friday, 14 July 2023, 11:05 AM
P557: Cost-effectiveness of infliximab vs. surgery for severe chronic ulcerative colitis: a Markov analysis
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Holubar1*, P. Dulai2, B. Piazik3, S. Finlayson4, B. Udeh5

Created: Thursday, 21 February 2019, 9:14 AM
P557: Long-term outcomes following laparoscopic ileocecal resection without any residual lesion for Crohn’s disease: a single-center observational study
Year: 2021
Source: ECCO'21 Virtual
Authors: Ge, X.(1);Zhou, W.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P557: Robotic surgery significantly improves outcomes for patients with inflammatory bowel disease
Year: 2022
Source: ECCO'22
Authors: Karategos, A.(1);Yassin, N.(1);
Created: Friday, 11 February 2022, 3:56 PM
P557: Sustained remission in inflammatory bowel disease patients after discontinuing infliximab; the ongoing reluctance to stop biologics
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Ryan*1, L. Coffey1, A. Mullen1, J. Leyden1, P. MacMathuna1

Created: Friday, 22 February 2019, 9:41 AM
P557: Utility of “trough levels” adalimumab determination in patients with inflammatory bowel disease. Estimation of individual pharmacokinetic parameters through population pharmacokinetic model
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Juan G.*1, Alvariño A.2, Mora M.3, Oltra L.3, Maroto N.3, Ferrer I.3, Hinojosa E.3, Hinojosa M.D.3, Hinojosa J.3

Created: Wednesday, 20 February 2019, 10:36 AM
P558 Validation of the ‘IBD Disk’ in clinical practice
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. FERGUSON1, N. Ding2, W. Connell2, J. Williams2, E. Wright2, M. Kamm2, A. Thompson2, M. Lust2, E. Flanagan2, C. Basnayake2

Created: Thursday, 30 January 2020, 10:12 AM
P558: Etrasimod for the treatment of ulcerative colitis: analysis of infection rates from the phase 3 ELEVATE UC 52 and ELEVATE UC 12 clinical trials
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Regueiro, M.(1);Siegmund, B.(2)*;Yarur, A.(3);Steinwurz, F.(4);Gecse, K.B.(5);Goetsch, M.(6);Bhattacharjee, A.(7);Wu, J.(8);Green, J.(9);McDonnell, A.(10);Crosby, C.(11);Lazin, K.(12);Ferreira Branquinho, D.(13);Modesto, I.(14);Abreu, M.T.(15);
Created: Friday, 14 July 2023, 11:05 AM
P558: Golimumab improves patient-reported work productivity and activity impairment in patients with ulcerative colitis: Interim results from a non-interventional trial in Germany
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Teich1, H. Grümmer2, E. Jörgensen3, T. Liceni4, F. Holtkamp-Endemann5, F. Cornillie6, S. Hohenberger7, T. Fischer7*

Created: Thursday, 21 February 2019, 9:14 AM
P558: Iterative ileocolonic resection for Crohn’s disease: a prospective multi-centric cohort study of the GETAID Chirurgie
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Abdalla1, A. Brouquet2, L. Maggiori3, P. Zerbib4, Q. Denost5, A. Germain6, E. Cotte7, L. Beyer-Berjot8, N. Munoz-Bongrand9, V. Desfourneaux10, A. Rahili11, J-P. Duffas12, K. Pautrat13, C. Denet14, V. Bridoux15, G. Meurette16, J-L. Faucheron17, J. Loriau18, F. Guillon19, E. Vicaut20, S. Benoist2, Y. Panis3, J. Lefevre*1

Created: Friday, 22 February 2019, 9:41 AM
P558: Medication Preference of 400 patients with mild to moderate Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Mackenzie-Smith, L.(1);Wüthrich, H.(2);Laoun, R.(2);
Created: Wednesday, 2 June 2021, 4:12 PM